In Vivo Cannabidiol Treatment Improves Endothelium-Dependent Vasorelaxation in Mesenteric Arteries of Zucker Diabetic Fatty Rats
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Vivo Cannabidiol Treatment Improves Endothelium-Dependent Vasorelaxation in Mesenteric Arteries of Zucker Diabetic Fatty Rats
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-05-18
DOI
10.3389/fphar.2017.00248
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors
- (2016) William H Hind et al. BRITISH JOURNAL OF PHARMACOLOGY
- Marijuana Use and Type 2 Diabetes Mellitus: a Review
- (2016) Stephen Sidney Current Diabetes Reports
- Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
- (2016) Khalid A. Jadoon et al. DIABETES CARE
- Cannabidiol and epilepsy: Rationale and therapeutic potential
- (2016) Antonio Leo et al. PHARMACOLOGICAL RESEARCH
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- (2016) Alline C. Campos et al. PHARMACOLOGICAL RESEARCH
- Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents
- (2016) Pius S. Fasinu et al. PHARMACOTHERAPY
- Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence
- (2016) Cathrin Rohleder et al. Frontiers in Pharmacology
- Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes
- (2015) Takayuki Matsumoto et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1activation
- (2015) Christopher P. Stanley et al. CARDIOVASCULAR RESEARCH
- Endothelial Dysfunction, Obesity and Insulin Resistance
- (2014) Dolores Prieto et al. Current Vascular Pharmacology
- A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain
- (2014) B. Hoggart et al. JOURNAL OF NEUROLOGY
- Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes
- (2013) Christopher P. Stanley et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Is the cardiovascular system a therapeutic target for cannabidiol?
- (2012) Christopher P. Stanley et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Endothelium-mediated control of vascular tone: COX-1 and COX-2 products
- (2011) Michel Félétou et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
- (2010) Mohanraj Rajesh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cannabinoid-Mediated Modulation of Neuropathic Pain and Microglial Accumulation in a Model of Murine Type I Diabetic Peripheral Neuropathic Pain
- (2010) Cory C Toth et al. Molecular Pain
- Time-dependent vascular actions of cannabidiol in the rat aorta
- (2009) Saoirse E. O'Sullivan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabidiol arrests onset of autoimmune diabetes in NOD mice
- (2007) Lola Weiss et al. NEUROPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation